U.S. Food & Drug Administration
LT Kelliann Wachrathit has worked at the FDA since 2013 as a pre-market scientific reviewer in the Center for Devices and Radiological Health (CDRH), Office of Device Evaluation (ODE), Division of Neurological and Physical Medicine Devices (DNPMD). Review areas include brain computer interfaces (BCI), nerve and muscle electrical stimulators, and other neurotherapeutic, physical medicine, and rehabilitation devices. She recently joined the United State Public Health Service in 2017. Prior to her role as a pre-market scientific reviewer, she conducted regulatory science research from 2010-2013 on peripheral and cortical neural interface devices in the Neural Implant Lab in the Division of Biomedical Physics (DBP) in the Office of Engineering and Science Laboratories (OSEL) in CDRH.